A Second Promising Alzheimer’s Treatment is Announced

There is a flurry of attention today on another promising Alzheimer’s drug. This one is made by Eli Lilly and is called donanemab. The company said yesterday that a clinical trial found that benefits from the medicine were promising enough that it plans to submit its findings to the FDA (U.S. Food & Drug Administration) and other regulators “to achieve …